A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity
Eric D. Laing, Spencer L. Sterling, Stephanie A. Richard, Shreshta Phogat, Emily C. Samuels, Nusrat J. Epsi, Lianying Yan, Nicole Moreno, Christian Coles, Jennifer Mehalko, Matthew Drew, Caroline English, Kevin K. Chung, G. Travis Clifton, View ORCID ProfileVincent J. Munster, Emmie de Wit, David Tribble, Brian K. Agan, Dominic Esposito, Charlotte Lanteri, Edward Mitre, Timothy H. Burgess, Christopher C. Broder
doi: https://doi.org/10.1101/2020.10.14.20207050
Eric D. Laing
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Spencer L. Sterling
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD USA
Stephanie A. Richard
2Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD USA
Shreshta Phogat
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD USA
Emily C. Samuels
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD USA
Nusrat J. Epsi
2Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD USA
Lianying Yan
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD USA
Nicole Moreno
2Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD USA
Christian Coles
2Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD USA
Jennifer Mehalko
4Protein Expression Laboratory, National Cancer Institute RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
Matthew Drew
4Protein Expression Laboratory, National Cancer Institute RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
Caroline English
2Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD USA
Kevin K. Chung
5Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
G. Travis Clifton
6Brooke Army Medical Center, JBSA Fort Sam Houston, TX, USA
Vincent J. Munster
7Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
Emmie de Wit
7Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA
David Tribble
2Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Brian K. Agan
2Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
3Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD USA
Dominic Esposito
4Protein Expression Laboratory, National Cancer Institute RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
Charlotte Lanteri
2Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Edward Mitre
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Timothy H. Burgess
2Infectious Diseases Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Christopher C. Broder
1Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Data Availability
The protocols and datasets used and/or analyzed during the current study are available from the corresponding author(s) on reasonable request.
Posted October 16, 2020.
A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity
Eric D. Laing, Spencer L. Sterling, Stephanie A. Richard, Shreshta Phogat, Emily C. Samuels, Nusrat J. Epsi, Lianying Yan, Nicole Moreno, Christian Coles, Jennifer Mehalko, Matthew Drew, Caroline English, Kevin K. Chung, G. Travis Clifton, Vincent J. Munster, Emmie de Wit, David Tribble, Brian K. Agan, Dominic Esposito, Charlotte Lanteri, Edward Mitre, Timothy H. Burgess, Christopher C. Broder
medRxiv 2020.10.14.20207050; doi: https://doi.org/10.1101/2020.10.14.20207050
A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity
Eric D. Laing, Spencer L. Sterling, Stephanie A. Richard, Shreshta Phogat, Emily C. Samuels, Nusrat J. Epsi, Lianying Yan, Nicole Moreno, Christian Coles, Jennifer Mehalko, Matthew Drew, Caroline English, Kevin K. Chung, G. Travis Clifton, Vincent J. Munster, Emmie de Wit, David Tribble, Brian K. Agan, Dominic Esposito, Charlotte Lanteri, Edward Mitre, Timothy H. Burgess, Christopher C. Broder
medRxiv 2020.10.14.20207050; doi: https://doi.org/10.1101/2020.10.14.20207050
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2853)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12561)
- Forensic Medicine (10)
- Gastroenterology (806)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2850)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (462)
- Neurology (4194)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6783)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)